繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

心脏测试实验室GAAP每股收益为-2.64美元,相差0.18美元

2024-09-13 04:50

  • Heart Test Laboratories press release (NASDAQ:HSCS): Q1 GAAP EPS of -$2.64 misses by $0.18.
  • Cash and cash equivalents of $4.3 million and shareholder’s equity of $5.9 million. Subsequent to the quarter end, the Company further strengthened its balance sheet by extending its cash runway with the closing of $1.9 million, net proceeds, in non-dilutive financing through an 18-month loan note and the 12-month extension of a $500,000 loan note to September 2025.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。